APA (7th ed.) Citation

L, O., F, P., M, P., C, B., P, D., B, F., . . . F, J. (2021). Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(11), 1203. https://doi.org/10.1200/JCO.20.02666

Chicago Style (17th ed.) Citation

L, Oberic, et al. "Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 39, no. 11 (2021): 1203. https://doi.org/10.1200/JCO.20.02666.

MLA (9th ed.) Citation

L, Oberic, et al. "Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 39, no. 11, 2021, p. 1203, https://doi.org/10.1200/JCO.20.02666.